Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.60 |
| ▸ | SQLE | Q14534 | 7/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL492564 | 1.00 | KMT2A (0.68) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL8011943 | 1.00 | KMT2A (0.68) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL11844741 | 0.98 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL11844736 | 0.98 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL158266 | 0.98 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL2250076 | 0.98 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL158315 | 0.98 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL1586840 | 0.98 | KMT2A (0.73) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL16371732 | 0.98 | KMT2A (0.65) | KMT2AALOX15MEN1CYP3A4ALDH1A1 | |
| SCHEMBL16371733 | 0.98 | KMT2A (0.65) | KMT2AALOX15MEN1CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 836 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119411248-A | Antibacterial polyester fiber for wiping and wiping cloth prepared from antibacterial polyester fiber | 江苏中石纤维股份有限公司 | 2025-02-11 | — | — | CN | claimed |
| US-12194020-B2 | Reversing baldness through cannabinoid receptor activation | POSTREL RICHARD (US) | 2025-01-14 | — | — | US | claimed |
| CN-117964484-A | Method for synthesizing gefarnate by using farnesene and derivatives thereof and application of gefarnate | 中国科学院青岛生物能源与过程研究所 | 2024-05-03 | — | — | CN | claimed |
| CN-117388390-A | Fructus aurantii quality marker and application thereof | 江西省、中国科学院庐山植物园 | 2024-01-12 | — | — | CN | claimed |
| CN-116284506-B | Gamma-cyclodextrin-geraniol derivative and preparation method and application thereof | 江南大学 | 2023-12-08 | — | — | CN | claimed |
| CN-116751427-A | Ultraviolet-resistant crosslinked polyvinyl chloride material for cables and preparation method thereof | 何有军 | 2023-09-15 | — | — | CN | claimed |
| CN-116284506-A | Gamma-cyclodextrin-geraniol derivative and preparation method and application thereof | 江南大学 | 2023-06-23 | — | — | CN | claimed |
| US-20220249434-A1 | Reversal of Baldness in Men and Women through Cannabinoid Receptor Activation | POSTREL RICHARD (US) | 2022-08-11 | — | — | US | claimed |
| US-11331300-B2 | Reversing baldness through follicle regeneration | POSTREL RICHARD (US) | 2022-05-17 | — | — | US | claimed |
| CN-113995890-A | Slow-release antibacterial medical catheter and preparation method thereof | 扬州市安健医疗器械有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-101538233-A | Preparation method of thiogeraniol | UNIV BEIJING SCIENCE & TECH | 2009-09-23 | — | — | CN | claimed |
| CN-101023747-A | Plant growth regulator and synthesizing method therefor | TAIYUAN TECHNOLOGY UNIV (CN) | 2007-08-29 | — | — | CN | claimed |
| CN-101023748-A | Adenine plant growth regulator and preparing method thereof | TAIYUAN TECHNOLOGY UNIV (CN) | 2007-08-29 | — | — | CN | claimed |
| US-20030028054-A1 | SYNTHESIS OF COENZYME Q10 UBIQUINONE | WEST DANIEL DAVID (US) | 2003-02-06 | — | — | US | claimed |
| US-6506915-B1 | Stereospecific synthesis of optically pure trans (E)isomer of coenzyme Q10 starting from geranyl bromide and 2,3,4,5-tetramethoxytoluene | WEST DANIEL DAVID (US) | 2003-01-14 | — | — | US | claimed |
| US-4229356-A | Production of vitamin K1 and vitamin K2 | WAKUNAGA YAKUHIN KABUSHIKI KAISHA (JP) | 1980-10-21 | — | — | US | claimed |
| US-4089873-A | Preparation of menaquinones | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1978-05-16 | — | — | US | claimed |
| US-4064150-A | SELECTIVE GAMMA-ALKYLATION OF ALPHA,BETA-UNSATURATED ACIDS WITH ALLYLIC ELECTROPHILES, DICOPPER(I) DIENOLATES | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1977-12-20 | — | — | US | claimed |
| US-3984475-A | IN ALKALI METAL HYDROXIDE AND A PHOSPHONIUM SALT AS THE CATALYST | KURARAY CO., LTD. (JA) | 1976-10-05 | — | — | US | claimed |
| US-3948958-A | Process for making 3-prenylated menaquinones and ether intermediates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1976-04-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030028054-A1 | SYNTHESIS OF COENZYME Q10 UBIQUINONE | NDUFB10, NDUFA10, SQLE | KMT2A 4404/4885ALOX15 386/4885MEN1 1690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.